Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan

<div>Kaplan–Meier analysis with log-rank test of the total hospital mortality in pioglitazone users (at least 4 weeks’ drug use within 3 months) and nonusers.</div>

Emergency Medicine International

fig3

Figure 3

Figure 3: Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan 

Figure 3 | Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan 